Involvement of aryl hydrocarbon receptor nuclear translocato in EGF-induced c-Jun/Sp1-mediated gene expression

Cellular and Molecular Life Sciences

Volumn 67, Issue 20, 2010, Pages 3523-3533

  Huang, Wan Chen ^a   Chen, Shu Ting ^a   Chang, Wei Chiao ^b,e   Chang, Kwang Yu ^c   Chang, Wen Chang ^a,d,e   Chen, Ben Kuen ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aryl hydrocarbon receptor nuclear translocator (ARNT); C Jun Sp1; Epidermal growth factor (EGF); Gene expression; Protein DNA interaction

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; EPIDERMAL GROWTH FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SP1; HYPOXIA INDUCIBLE FACTOR 1BETA; LIPOXYGENASE; PROTEIN C JUN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POINT MUTATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; DRUG EFFECT; GENETICS; METABOLISM; TUMOR CELL LINE;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BINDING SITES; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOXYGENASE; MODELS, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 77957354597     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0392-9     Document Type: Article

References (38)

1. Kewley RJ, Whitelaw ML, Chapman-Smith A (2004) The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 36:189-204
2. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-407
3. Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E (1998) Role of HIF-1[alpha] in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490
4. Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309-334
5. Woods SL, Whitelaw ML (2002) Differential activities of murine single minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-Sim homology transcription factors. J Biol Chem 277:10236-10243
6. Kozak KR, Abbott B, Hankinson O (1997) ARNT-deficient mice and placental differentiation. Dev Biol 191:297-305
7. Moffett P, Pelletier J (2000) Different transcriptional properties of mSim-1 and mSim-2. FEBS Lett 466:80-86
8. Wright CW, Duckett CS (2009) The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription. Science 323:251-255
9. Chang KY, Shen MR, Lee MY, Wang WL, Su WC, Chang WC, Chen BK (2009) Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma. J Biol Chem 284:9908-9916
10. van Cruijsen H, Giaccone G, Hoekman K (2005) Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies. Int J Cancer 117:883-888
11. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183-232
12. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2:127-137
13. Chen BK, Chang WC (2000) Functional interaction between c-Jun. and promoter factor Sp1 in epidermal growth factorinduced gene expression of human 12 (S)-lipoxygenase. Proc Natl Acad Sci USA 97:10406-10411
14. Chen BK, Kung HC, Tsai TY, Chang WC (2000) Essential role of mitogen-activated protein kinase pathway and c-Jun. induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase. Mol Pharmacol 157:153-161
15. Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, Zacharek A, Guo Y, Milanini J, Pages G, Honn KV (2006) Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem 281:18601-18609
16. Kardassis D, Papakosta P, Pardali K, Moustakas A (1999) c-Jun. transactivates the promoter of the human p21 (WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem 274:29572-29581
17. Numayama-Tsuruta K, Kobayashi A, Sogawa K, Fujii-Kuriyama Y (1997) A point mutation responsible for defective function of the aryl-hydrocarbon- receptor nuclear translocator in mutant Hepa-1c1c7 cells. Eur J Biochem 246:486-495
18. Liu YW, Arakawa T, Yamamoto S, Chang WC (1997) Transcriptional activation of human 12-lipoxygenase gene promoter is mediated through Sp1 consensus sites in A431 cells. Biochem J 324:133-140
19. Tsou JH, Chang KY, Wang WC, Tseng JT, Su WC, Hung LY, Chang WC, Chen BK (2008) Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells. Nucleic Acids Res 36:217-227
20. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
21. Saccani S, Pantano S, Natoli G (2001) Two waves of nuclear factor {kappa}B recruitment to target promoters. J Exp Med 193:1351-1360
22. Zhu Y, Saunders MA, Yeh H, Deng W-g, Wu KK (2002) Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins. J Biol Chem 277:6923-6928
23. Dong Z, Crawford HC, Lavrovsky V, Taub D, Watts R, Matrisian LM, Colburn NH (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol- 13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog 19:204-212
24. Blaine SA, Wick M, Dessev C, Nemenoff RA (2001) Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J Biol Chem 276:42737-42743
25. Kardassis D, Papakosta P, Pardali K, Moustakas A (1999) c-Jun. transactivates the promoter of the human p21WAF1/Cip1 gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem 274:29572-29581
26. Timar J, Raso E, Dome B, Li L, Grignon D, Nie D, Honn KV, Hagmann W (2000) Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 87:37-43
27. Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, Honn KV (2007) Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 26:503-524
28. Cordero-Erausquin M, Marubio LM, Klink R, Changeux JP (2000) Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21:211-217
29. Leslie CC (1997) Properties and regulation of cytosolic phospholipase A2. J Biol Chem 272:16709-16712
30. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN (1995) Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 133:501-511
31. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ (1999) The p21 (Cip1) and p27 (Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583
32. Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2:803-811
33. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng Y-H, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR (2005) Loss of ARNT/HIF1[beta] mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349
34. Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345-350
35. Sutter CH, Yin H, Li Y, Mammen JS, Bodreddigari S, Stevens G, Cole JA, Sutter TR (2009) EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc Natl Acad Sci USA 106:4266-4271
36. Chen BK, Huang CC, Chang WC, Chen YJ, Kikkawa U, Nakahama K-I, Morita I, Chang WC (2007) PP2B-mediated dephosphorylation of c-Jun. C terminus regulates phorbol esterinduced c-Jun/Sp1 interaction in A431 cells. Mol Biol Cell 18:1118-1127
37. Tojo M, Matsuzaki K, Minami T, Honda Y, Yasuda H, Chiba T, Saya H, Fujii-Kuriyama Y, Nakao M (2002) The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system. J Biol Chem 277:46576-46585
38. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830-5835